Table 1.
Overview of clinical and psychometric measurements
| Abbreviation | Full name and reference | Timepoint |
|---|---|---|
| Neurological deficits and functional impairment | ||
| NIHSS | National Institute of Health stroke scale [26] | Baseline, months 3, 6, 9 and 12 |
| mRS | modified Rankin scale [27] | Baseline, months 3, 6, 9 and 12 |
| BI | Barthel index [28] | Baseline, months 3, 6, 9 and 12 |
| Depression and anxiety symptoms | ||
| PHQ-9 | Patient health questionnaire 9 items [29] | Every month |
| HADS | Hospital anxiety and depression scale [30] | Baseline, months 3, 6, 9 and 12 |
| Quality of life | ||
| EQ-5D | EuroQoL 5 dimensions [31] | Every month |
| SF-36 | Short form (36) health survey [32] | Baseline, months 3, 6, 9 and 12 |
| Adherence | ||
| AAQ | Adherence assessment questionnaire [33] | Baseline, months 6 and 12 |
| ABQ | Adherence barriers questionnaire [34] | Baseline, months 6 and 12 |
| Empowerment | ||
| HCEI | Healthcare empowerment inventory [35] | Baseline, months 3, 6, 9 and 12 |
| Neuropsychological and cognitive impairment | ||
| BT | Bells test [36] | Irregular |
| TMT | Trail making test [37] | Irregular |
| MMSE | Mini mental status examination [38] | Baseline, months 3, 6, 9 and 12 |